Cubist Systematic Strategies’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Hold |
0
| – | – | – | 2825 |
|
|
2023
Q2 | – | Sell |
-34,946
| Closed | -$3.18M | – | 3233 |
|
|
2023
Q1 | $3.18M | Buy |
34,946
+27,627
| +377% | +$2.51M | 0.02% | 857 |
|
|
2022
Q4 | $278K | Sell |
7,319
-24,065
| -77% | -$914K | ﹤0.01% | 2491 |
|
|
2022
Q3 | $789K | Buy |
31,384
+12,005
| +62% | +$302K | ﹤0.01% | 2224 |
|
|
2022
Q2 | $589K | Sell |
19,379
-8,810
| -31% | -$268K | ﹤0.01% | 2500 |
|
|
2022
Q1 | $923K | Sell |
28,189
-15,432
| -35% | -$505K | 0.01% | 2089 |
|
|
2021
Q4 | $1.15M | Buy |
43,621
+11,886
| +37% | +$313K | 0.01% | 1817 |
|
|
2021
Q3 | $3.19M | Buy |
31,735
+11,713
| +59% | +$1.18M | 0.04% | 719 |
|
|
2021
Q2 | $2.83M | Sell |
20,022
-15,295
| -43% | -$2.16M | 0.03% | 864 |
|
|
2021
Q1 | $3.52M | Buy |
35,317
+22,410
| +174% | +$2.23M | 0.05% | 645 |
|
|
2020
Q4 | $1.6M | Buy |
12,907
+3,004
| +30% | +$371K | 0.02% | 1098 |
|
|
2020
Q3 | $965K | Sell |
9,903
-4,099
| -29% | -$399K | 0.01% | 1357 |
|
|
2020
Q2 | $2.19M | Buy |
14,002
+13,267
| +1,805% | +$2.07M | 0.04% | 729 |
|
|
2020
Q1 | $106K | Sell |
735
-1,448
| -66% | -$209K | ﹤0.01% | 1897 |
|
|
2019
Q4 | $446K | Buy |
2,183
+483
| +28% | +$98.7K | 0.01% | 1613 |
|
|
2019
Q3 | $136K | Buy |
1,700
+1,300
| +325% | +$104K | ﹤0.01% | 1877 |
|
|
2019
Q2 | $38K | Sell |
400
-1,000
| -71% | -$95K | ﹤0.01% | 2352 |
|
|
2019
Q1 | $120K | Sell |
1,400
-13,311
| -90% | -$1.14M | ﹤0.01% | 1956 |
|
|
2018
Q4 | $825K | Buy |
14,711
+12,805
| +672% | +$718K | 0.04% | 658 |
|
|
2018
Q3 | $156K | Sell |
1,906
-2,494
| -57% | -$204K | 0.01% | 1470 |
|
|
2018
Q2 | $154K | Buy |
+4,400
| New | +$154K | 0.01% | 1434 |
|